Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully understand the… Read More